Web Stats Provided By Google Analytics

Monday, January 22, 2018

Zacks: Brokerages Anticipate CymaBay Therapeutics Inc (CBAY) Will...

... Fund Management LLC bought a new stake in CymaBay Therapeutics during the third quarter worth about $404,000. Ardsley Advisory Partners lifted its stake in CymaBay Therapeutics by 66.2% during the second quarter. Ardsley Advisory Partners now owns ...
https://www.americanbankingnews.com/2018/01/22/zacks-brokerages-anticipate-cymabay-therapeutics-inc-cbay-will-announce-quarterly-sales-of-6-75-million.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

No comments:

Post a Comment

Popular Ardsley Roundup Posts